Elective Nodal Irradiation (ENI) Doesn't Appear to Provide a Clear Benefit for Patients With Unresectable Non–Small-Cell Lung Cancer (NSCLC)
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference12 articles.
1. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy;Belderbos;Int J Radiat Oncol Biol Phys,2006
2. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy;Rosenzweig;Int J Radiat Oncol Biol Phys,2001
3. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial;Hayman;J Clin Oncol,2001
4. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma;Le Chevalier;Lung Cancer,1994
5. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 [abstract #2499]. 2003 annual meeting of ASCO;Curran;Proc Am Soc Clin Oncol,2003
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update;Lung Cancer: Targets and Therapy;2018-09
2. Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC;Journal of Thoracic Oncology;2018-08
3. Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers;International Journal of Molecular Imaging;2012-05-14
4. Esophagitis, Treatment-Related Toxicity in Non-Small Cell Lung Cancer;Reviews on Recent Clinical Trials;2012-02-01
5. Protons Safely Allow Coverage of High-Risk Nodes for Patients with Regionally Advanced Non-Small-Cell Lung Cancer;Technology in Cancer Research & Treatment;2011-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3